A detailed history of Erts Wealth Advisors, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Erts Wealth Advisors, LLC holds 318 shares of LLY stock, worth $237,291. This represents 0.05% of its overall portfolio holdings.

Number of Shares
318
Previous 318 -0.0%
Holding current value
$237,291
Previous $287,000 2.09%
% of portfolio
0.05%
Previous 0.06%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 23, 2024

BUY
$592.2 - $792.28 $188,319 - $251,945
318 New
318 $247,000
Q4 2018

Feb 14, 2019

BUY
$105.9 - $118.64 $3,071 - $3,440
29 New
29 $3,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $709B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Erts Wealth Advisors, LLC Portfolio

Follow Erts Wealth Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Erts Wealth Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Erts Wealth Advisors, LLC with notifications on news.